Economic Burden of Cancer in Korea during 2000-2010
2
조회
0
다운로드
25
인용
0
참고문헌
키워드
초록
Purpose This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site, gender, age group, and cost component. Materials and Methods Data came from national health insurance claims data and information from Statistics Korea. Based on the cost of illness method, this study calculated direct, morbidity and mortality cost of cancer in the nation during 2000-2010 by cancer site, gender, and age group. Results With an average annual growth rate of 8.9%, the economic burden of cancer in Korea increased from 11,424 to 20,858 million US$ (current US dollars) during 2000-2010. Colorectal, thyroid, and breast cancers became more significant during the period, i.e., the 5th/837, the 11th/257, and the 7th/529 in 2000 to the 3rd/2,210, the 5th/1,724, and the 6th/1,659 in 2010, respectively (rank/amount in million US$ for the total population). In addition, liver and stomach cancers were prominent during the period in terms of the same measures, i.e., the 1st/2,065 and the 2nd/2,036 in 2000 to the 1st/3,114 and the 2nd/3,046 in 2010, respectively. Finally, the share of mortality cost in the total burden dropped from 71% to 51% in Korea during 2000-2010, led by colorectal, thyroid, breast, and prostate cancers during the period. These results show that the economic burden of cancer in Korea is characterized by an increasing importance of chronic components. Conclusion Incorporation of distinctive epidemiological, sociocultural contexts into Korea’s cancer control program, with greater emphasis on primary prevention such as sodium-controlled diet and hepatitis B vaccination, may be needed.
Abstract
Purpose This study estimated the economic burden of cancer in Korea during 2000-2010 by cancer site, gender, age group, and cost component. Materials and Methods Data came from national health insurance claims data and information from Statistics Korea. Based on the cost of illness method, this study calculated direct, morbidity and mortality cost of cancer in the nation during 2000-2010 by cancer site, gender, and age group. Results With an average annual growth rate of 8.9%, the economic burden of cancer in Korea increased from 11,424 to 20,858 million US$ (current US dollars) during 2000-2010. Colorectal, thyroid, and breast cancers became more significant during the period, i.e., the 5th/837, the 11th/257, and the 7th/529 in 2000 to the 3rd/2,210, the 5th/1,724, and the 6th/1,659 in 2010, respectively (rank/amount in million US$ for the total population). In addition, liver and stomach cancers were prominent during the period in terms of the same measures, i.e., the 1st/2,065 and the 2nd/2,036 in 2000 to the 1st/3,114 and the 2nd/3,046 in 2010, respectively. Finally, the share of mortality cost in the total burden dropped from 71% to 51% in Korea during 2000-2010, led by colorectal, thyroid, breast, and prostate cancers during the period. These results show that the economic burden of cancer in Korea is characterized by an increasing importance of chronic components. Conclusion Incorporation of distinctive epidemiological, sociocultural contexts into Korea’s cancer control program, with greater emphasis on primary prevention such as sodium-controlled diet and hepatitis B vaccination, may be needed.
참고문헌 (24)
- "World development indicators" (2013)[URL]
- Jemal A, "Cancer statistics, 2008", CA Cancer J Clin, 58, pp.71~96 (2008)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회[DOI]
- Cooper BS, "The economic cost of illness revisited", Soc Secur Bull, 39, pp.21~36 (1976)
- National Heart, Lung and Blood Institute, "NHLBI fact book, fiscal year 2007" (2007), National Heart, Lung and Blood Institute
- Park JH, "Burden of cancer in Korea during 2000-2020", Cancer Epidemiol, 37, pp.353~359 (2013)
- Brown ML, "The burden of illness of cancer : economic cost and quality of life", Annu Rev Public Health, 22, pp.91~113 (2001)
- Economic burden of illness in Canada, "Policy Research Division, Strategic Policy Directorate, Population and Public Health Branch, Health Canada", Health Canada, ~ (2002)
- NSW Cancer Council, "Cost of cancer in NSW" (2007), NSW Cancer Council
- Jonsson B, "The burden and cost of cancer", Ann Oncol, 18(Suppl 3), pp.8~22 (2007)
- Yabroff KR, "Economic burden of cancer in the United States : estimates, projections and future research", Cancer Epidemiol Biomarkers Prev, 20, pp.2006~2014 (2011)
- Kim SG, "The economic burden of cancer in Korea in 2002", Eur J Cancer Care(Engl), 17, pp.136~144 (2008)
- 김진희, "2005년 암의 경제적 비용부담 추계", 예방의학회지, 42(3), pp.190~198 (2009), 대한예방의학회
- World population ageing 2009, "United Nations", Department of Economic and Social Affairs of the United Nations, ~ (2009)
- Korea health insurance statistical yearbook, 2000-2010, "Korea Health Insurance Corporation", Korea Health Insurance Corporation, ~ (2010)
- A survey on out-ofpocket expenditure of patients enrolled in health insurance, 2005-2010, "Korea Health Insurance Corporation", Korea Health Insurance Corporation, ~
- "Seoul: Korean National Statistical Service; 2012-2013"[URL]
- Bradley CJ, "Productivity costs of cancer mortality in the United States : 2000-2020", J Natl Cancer Inst, 100, pp.1763~1770 (2008)
- Lee SK, "Socio-economic, dietary, activity, nutrition and body weight transitions in South Korea", Public Health Nutr, 6, pp.665~674 (2003)
- 강민지, "우리나라 성인의 식사패턴 변화 추세 - 1998, 2001, 2005년도 국민건강영양조사자료를 이용하여 -", Journal of Nutrition and Health, 44(2), pp.152~161 (2011), 한국영양학회
- 2020 Vision and strategy of health service industry in Korea, "Jeong GT", Korea Institute for Industrial Economics and Trade Policy, ~, pp.KIET Policy Report 2007-66 (2007)
- "National cancer control programs" (2013)[URL]
- OECD economic surveys: Korea 2012, "Organisation for Economic Cooperation and Development (OECD)", OECD, 48~ (2012)
- Ngoma T., "World Health Organization cancer priorities in developing countries", Ann Oncol, 17(Suppl 8), pp.9~14 (2006)